These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1027 related articles for article (PubMed ID: 19762686)

  • 1. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA; Simeone SM; Nikonova A; Ebrahimian T; Deschênes ME; Coffman TM; Paradis P; Schiffrin EL
    Circ Res; 2009 Oct; 105(9):852-9. PubMed ID: 19762686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
    Mazak I; Fiebeler A; Muller DN; Park JK; Shagdarsuren E; Lindschau C; Dechend R; Viedt C; Pilz B; Haller H; Luft FC
    Circulation; 2004 Jun; 109(22):2792-800. PubMed ID: 15159288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
    Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
    Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
    Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
    Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
    Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small interfering RNA knocks down heat shock factor-1 (HSF-1) and exacerbates pro-inflammatory activation of NF-kappaB and AP-1 in vascular smooth muscle cells.
    Chen Y; Currie RW
    Cardiovasc Res; 2006 Jan; 69(1):66-75. PubMed ID: 16061216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
    Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
    Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
    Jaffe IZ; Mendelsohn ME
    Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs.
    Cui R; Tieu B; Recinos A; Tilton RG; Brasier AR
    Circ Res; 2006 Sep; 99(7):723-30. PubMed ID: 16960103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
    Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
    Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase.
    Liu D; Gao L; Roy SK; Cornish KG; Zucker IH
    Circ Res; 2006 Oct; 99(9):1004-11. PubMed ID: 17008603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
    Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
    Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
    Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
    J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells.
    Rautureau Y; Paradis P; Schiffrin EL
    Steroids; 2011 Aug; 76(9):834-9. PubMed ID: 21371487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla.
    Chan SH; Wang LL; Tseng HL; Chan JY
    J Hypertens; 2007 Sep; 25(9):1845-61. PubMed ID: 17762649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.